Regarding “The use of donated products to train residents to perform injectable cosmetic procedures” - 13/12/14
Doi : 10.1016/j.jaad.2014.08.049
Julie M. Dhossche, BA a, Robert T. Brodell, MD b, c, d, Kimberley H.M. Ward, MD b, ⁎ 
a School of Medicine, University of Mississippi Medical Center, Jackson, Mississippi
b Department of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi
c Department of Pathology, University of Mississippi Medical Center, Jackson, Mississippi
d University of Rochester School of Medicine and Dentistry, New York
∗Correspondence to: Kimberley H. M. Ward, MD, Department of Dermatology, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Disclosure: Dr Brodell discloses the following potential conflicts of interest: honoraria have been received from presentations for Allergan, Galderma Laboratories, LP, and PharmaDerm, a division of Nycomed US Inc. Consultant fees have been received from Galderma Laboratories, LP and Hoffman-La Roche. Clinical trials have been performed for Genentech and Janssen Biotech Inc. Ms Dhossche and Dr Ward have no conflicts of interest to declare. |
© 2014
Publié par Elsevier Masson SAS.
Vol 72 - N° 1
P. 197-198 - janvier 2015 Retour au numéro
Article précédent
- Comments on “Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: A randomized controlled trial”
- Young Bok Lee, Yong-Gyu Park
- Reply: Injectable products considered “samples”
- Charlene Lam, Joshua S. Crites, Jennie T. Clarke, Jeffrey J. Miller, Joslyn S. Kirby
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?